Masong, Harmelene C.
HRN: 10-67-36 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/02/2022
CEFTRIAXONE 1G (VIAL)
09/02/2022
09/08/2022
IV DRIP
2 Grams
OD
Uti, Atp
Waiting Final Action
Indication: Empiric Type of Infection: Eye, Ear, Nose, Throat, & MouthReproductive Tract Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes